The serum levels of proinsulin and their relationship with IGFBP-1 in obese children

Diabetes, Obesity and Metabolism

Volumn 8, Issue 2, 2006, Pages 192-196

  Kamoda, T ^a   Saitoh, H ^a   Inudoh, M ^a   Miyazaki, K ^a   Matsui, A ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Children; IGFBP 1; Insulin resistance; Obesity; Proinsulin

Indexed keywords

IMMUNOREACTIVE INSULIN; PROINSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

EID: 33645992443     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00479.x     Document Type: Article

References (30)

1. Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila) 1998; 37: 111-115.
2. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 2003; 107: 1448-1453.
3. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1988; 31: 355-360.
4. Temple RC, Clark PM, Nagi DK, Schneider AE, Yudkin JS, Hales CN. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 1990; 32: 689-693.
5. Saad MF, Kahn SE, Nelson RG et al. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1990 ; 70: 1247-1253.
6. Mogul HR, Marshall M, Frey M et al. Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. J Clin Endocrinol Metab 1996; 81: 4492-4495.
7. Gibson JA, Westwood M, Young RJ, White A. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). J Clin Endocrinol Metab 1996; 81: 860-863.
8. Mohamed-Ali V, Pinkney JH, Panahloo A, Cwyfan- Hughes S, Holly JM, Yudkin JS. Insulin-like growth factor binding protein-1 in NIDDM. relationship with the insulin resistance syndrome. Clin Endocrinol 1999; 50: 221-228.
9. Tanner JM. Growth at Adolescence, 2nd edn. Oxford: Blackwell Science 1962.
10. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987; 30: 698-702.
11. Haffner SM, Bowsher RR, Mykkanen L et al. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes 1994; 43: 1490-1493.
12. Roder ME, Vaag A, Hartling SG et al. Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995; 80: 2359-2363.
13. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY. Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 1995; 44: 173-179.
14. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M. Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 1995; 38: 1176-1182.
15. Kahn SE, Halban PA. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 1997; 46: 1725-1732.
16. Roder ME, Porte D Jr, Schwartz RS, Kahn SE. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 604-608.
17. Porte D Jr, Kahn SE. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction? Diabetes 1989; 38: 1333-1336.
18. Rachman J, Levy JC, Barrow BA, Manley SE, Turner RC. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy. Diabetes 1997; 46: 1557-1562.
19. Lindahl B, Dinesen B, Eliasson M, Roder M, Hallmans G, Stegmayr B. High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke 2000; 31: 2936-2941.
20. Lindahl B, Dinesen B, Eliasson M et al. High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. Metabolism 1999; 48: 1197-1202.
21. Yudkin JS, Denver AE, Mohamed-Ali V et al. The relationship of concentrations of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence. A study of two ethnic groups. Diabetes Care 1997; 20: 1093-1100.
22. Rosenbloom AL, Starr JI, Juhn D, Rubenstein AH. Serum proinsulin in children and adolescents with chemical diabetes. Diabetes 1975; 24: 753-757.
23. Burghen GA, Etteldorf JN, Trouy RL, Kitabchi AE. Insulin and proinsulin in normal and chemical diabetic children. J Pediatr 1976; 89: 48-53.
24. Sinha R, Fisch G, Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802-810.
25. Chin D, Oberfield SE, Silfen ME et al. Proinsulin in girls: Relationship to obesity, hyperinsulinemia, and puberty. J Clin Endocrinol Metab 2002; 87: 4673-4677.
26. Lee PDK, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: Recent findings and new directions. Proc Soc Exp Biol Med 1997 ; 216: 319-357.
27. Conover CA, Lee PDK, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355-1360.
28. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 1994; 79: 1735-1741.
29. Saitoh H, Kamoda T, Nakahara S, Hirano T, Matsui A. Insulin-like growth factor binding protein-1 as a predictor of glucose-stimulated hyperinsulinemia in prepubertal obese children. Eur J Endocrinol 1999; 140: 231-234.
30. Bergenstal RM, Cohen RM, Lever E et al. The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes. J Clin Endocrinol Metab 1984; 58: 973-979.